Tectonic Therapeutic (TECX) Net Equity Issued and Repurchased (2017 - 2024)
Tectonic Therapeutic's (TECX) quarterly Net Equity Issued and Repurchased came in at $4000.0 in Q1 2024, down 69.23% year-on-year from $13000.0 in Q2 2023, and down 94.52% on a QoQ basis from $73000.0 in Q3 2023.
Tectonic Therapeutic (TECX) Net Equity Issued and Repurchased (2017 - 2024) Analysis & Trends
Tectonic Therapeutic (TECX) has 7 years of Net Equity Issued and Repurchased data on file, last reported at $4000.0 in Q1 2024.
- On a quarterly basis, Net Equity Issued and Repurchased fell 69.23% year-over-year to $4000.0 in Q1 2024; TTM through Mar 2024 was $77000.0, a 2.67% increase from a year earlier, with the FY2023 full-year figure at $86000.0, down 57.84% from the prior year.
- Net Equity Issued and Repurchased for Q1 2024 stood at $4000.0, down from $73000.0 in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for TECX reached as high as $93.6 million in Q1 2020 and fell as low as -$93.6 million in Q3 2020.
- Historically, Net Equity Issued and Repurchased has averaged $47785.7 across 5 years, with a median of $8500.0 in 2023.
- Across the five-year window, Net Equity Issued and Repurchased tumbled 101.88% in 2021 and jumped 378.43% in 2022, its largest moves.
- Year by year, Net Equity Issued and Repurchased stood at -$8.0 million in 2020, then jumped by 105.19% to $413000.0 in 2021, then tumbled by 99.76% to $1000.0 in 2022, then soared by 7200.0% to $73000.0 in 2023, then slumped by 94.52% to $4000.0 in 2024.
- Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $4000.0 in Q1 2024, $73000.0 in Q3 2023, and $13000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Tectonic Therapeutic | 595.23 Mn | 595.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 4,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Sep 30, 2023 | 73,000.00 |
| Sep 30, 2023 | 73,000.00 |
| Mar 31, 2023 | 13,000.00 |
| Mar 31, 2023 | 13,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | 60,000.00 |
| Sep 30, 2022 | 60,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 142,000.00 |
| Mar 31, 2022 | 142,000.00 |
| Dec 31, 2021 | 413,000.00 |
| Dec 31, 2021 | 413,000.00 |
| Jun 30, 2021 | -153,000.00 |
| Jun 30, 2021 | -153,000.00 |
| Mar 31, 2021 | -51,000.00 |
| Mar 31, 2021 | -51,000.00 |